PNV 0.85% $2.32 polynovo limited

Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,377 Posts.
    lightbulb Created with Sketch. 1106
    Hi,
    That trial has no bearing on financials for possibly years.
    Looks like we are returning to the old days of sales updates until
    they are not or distributor announcements for somewhere that no one has heard off.

    Holders got burnt last time hope it does not repeat.

    Aloha.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.